Memantine Merz

RSS

memantine hydrochloride

Authorised
This medicine is authorised for use in the European Union.

Overview

This is a summary of the European public assessment report (EPAR) for Memantine Merz. It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and its recommendations on the conditions of use for Memantine Merz.

This EPAR was last updated on 05/11/2019

Authorisation details

Product details
Name
Memantine Merz
Agency product number
EMEA/H/C/002711
Active substance
memantine hydrochloride
International non-proprietary name (INN) or common name
memantine hydrochloride
Therapeutic area (MeSH)
Alzheimer Disease
Anatomical therapeutic chemical (ATC) code
N06DX01
Publication details
Marketing-authorisation holder
Merz Pharmaceuticals GmbH  
Revision
6
Date of issue of marketing authorisation valid throughout the European Union
22/11/2012
Contact address
Merz Pharmaceuticals GmbH
Eckenheimer Landstr. 100
D-60318 Frankfurt
Germany

Product information

29/05/2019 Memantine Merz - EMEA/H/C/002711 - WS/1579

Contents

Please note that the size of the above document can exceed 50 pages.

You are therefore advised to be selective about which sections or pages you wish to print.

Pharmacotherapeutic group

Other Anti dementia drugs

Therapeutic indication

Treatment of patients with moderate to severe Alzheimer’s disease.

Assessment history

How useful was this page?

Add your rating